In the present study, we first investigated the performance of [99mTc]Tc-DB8 in male patients with PCa, collecting new information on GRPR-expression levels in PCa, assessing the tolerability and safety of the agent, and evaluating biodistribution and dosimetry calculations in men. Here, GRPR is linked to posterior cortical atrophy.